SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-026029
Filing Date
2019-05-01
Accepted
2019-05-01 16:21:03
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7737_110q.htm 10-Q 772313
2 EX-31.1 a19-7737_1ex31d1.htm EX-31.1 9799
3 EX-31.2 a19-7737_1ex31d2.htm EX-31.2 9783
4 EX-32 a19-7737_1ex32.htm EX-32 11495
  Complete submission text file 0001104659-19-026029.txt   4957090

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20190331.xml EX-101.INS 1241292
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20190331.xsd EX-101.SCH 39021
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20190331_cal.xml EX-101.CAL 67706
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20190331_def.xml EX-101.DEF 159788
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20190331_lab.xml EX-101.LAB 372070
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20190331_pre.xml EX-101.PRE 300860
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 19787863
SIC: 2834 Pharmaceutical Preparations